Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: 0.26 + 348 + web  Related to the article below (Last Update: 8/5/2008)

Cascade Bancorp (Oregon) Announces Second Quarter 2008 Net Income ...
MSN Money - Jul 24, 2008
For further information on Bank of the Cascades, please visit our web site at http://www.botc.com. This release contains forward-looking statements that are ...CACB
Washington Trust Announces Increased Second Quarter 2008 Earnings
MarketWatch - Jul 21, 2008
Investor information is available on the Corporation's web site: www.washtrust.com. This press release contains certain statements that may be considered ...WASH
LoopNet, Inc. Announces Second Quarter 2008 Financial Results
Trading Markets (press release), CA - Jul 30, 2008
Investors may also listen to a live web cast of the conference call on the investor relations section of our website at investor.LoopNet.com/events.cfm. ...LOOP
Source: Google News

Whole-lake food-web manipulation as a means to study community interactions in a small ecosystem -
E van Donk, MP Grimm, RD Gulati, JPG Klein … - Hydrobiologia, 1990 - Springer
... Fig, 1. Chlorophyll-a concentrations in Lake Zwemlust before and after food-web
manipulation. Page 5. ... 279 07-05 19 0.22 0.26 0.05 348 0.77 08-02 18 0.59 ...

[PDF] Perturbation theory based equation of state for polar molecular fluids: II. Fluid mixtures -
SV Churakov, M Gottschalk - Geochimica et Cosmochimica Acta, 2003 - people.web.psi.ch
Page 1. doi:10.1016/S0016-7037(02)01348-0 Perturbation theory based equation
of state for polar molecular fluids: II. Fluid mixtures ...

The chelation of metal ions by the acylpolyamine toxins from the web-spider Nephilengys cruentata: … -
MF Manzoli-Palma, N Gobbi, MS Palma - Chemoecology, 2006 - Springer
... chelation by the acylpolyamine toxins, the toxicity both of the crude venom of the
orb-web spider N ... JSTX-3 + Mg +2 (0.26 ng/?l ... 348.qxd 11/11/06 4:35 PM Page 205 ...

Coastal food web structure, carbon storage, and nitrogen retention regulated by consumer pressure … -
B Worm, HK Lotze, U Sommer - Limnology and Oceanography, 2000 - JSTOR
... 0.0225 GXN 3 0.13 2.23 0.1104 Error 24 0.06 Time 8 3.81 74.92 0.0001 TXG 8 0.45
8.84 0.0001 TXN 24 0.26 5.17 0.0001 ... 348. Coastal food web structure , AND ...

… regulation in snowshoe hare and Canadian lynx: Asymmetric food web configurations between hare and … -
NC Stenseth, W Falck, ON Bj?rnstad, CJ Krebs - Proceedings of the National Academy of Sciences of the …, 1997 - pubmedcentral.nih.gov
... from 0.01 to 0.48 with a mean of 0.26); the lagged ... Despite the complexity of the
boreal food web, the realized ... Philos Trans R Soc London A. 1994;348:325?341. ...

[PDF] WebQual: a measure of Web site quality
ET Loiacono, RT Watson, DL Goodhue - 2002 Marketing Educators? Conference: Marketing Theory and …, 2002 - terry.uga.edu
Page 1. 1 WebQual?: A Measure of Web Site Quality Eleanor T. Loiacono ... 0037
Page 2. 2 WebQual?: A Measure of Web Site Quality Eleanor T ...

[PDF] Detecting session boundaries from Web user logs -
D He, A Goker - Proceedings of the 22nd annual colloquium on information …, 2000 - umiacs.umd.edu
... 1 84.07% 12.51% 2.20% 0.65% 0.26% 0.14% 99.83 ... Data Preparation for Mining World Wide
Web Browsing Patterns ... 6th InternationalSymposium, ISMIS?91, pages 348?357 ...

Cancer risk in 348 French MSH2 or MLH1 gene carriers -
Y Parc, C Boisson, G Thomas, S Olschwang - British Medical Journal, 2003 - jmg.bmj.com
... Thus, at the end of the recruitment procedure, a total of 348 gene carriers ... failed
to show a significant difference among families (p=0.26; simulation showed ...

Short-Term Efficacy of a Web-Based Computer-Tailored Nutrition Intervention: Main Effects and … -
A Oenema, F Tan, J Brug - Annals of Behavioral Medicine, 2005 - Lawrence Earlbaum
... Credibility 1.45 1.37 1.70 1.47 2.70 Usefulness 1.31 1.41 1.23 1.55 0.26 ... Web-Based
Tailored Nutrition Education 59 TABLE 3 ... Vegetables n 361 348 361 348 ...

Cyclosa turbinata (Araneae, Araneidae): Prey discrimination via web-borne vibrations
RB Suter - Behavioral Ecology and Sociobiology, 1978 - Springer
... 289 the spiders were actively feeding at the time of prey impact on the web. ...
1,46+0.23 N= i1 ; Halictus sp. 1.90_+0.26 N= I1 ; S. cerealella 2.77_+0.42 N=9. ...

Source: Google Scholar

Organon's Sugammadex Demonstrated A 9-12 Times Faster Recovery In Phase III Pivotal Trial Compared To Neostigmine
The Aurora trial compared the efficacy of sugammadex and neostigmine for the reversal of shallow neuromuscular blockade induced by single or multiple doses of either rocuronium (Esmeron®/Zemuron®) or vecuronium (Norcuron®).

"Sugammadex has shown a rapid and complete reversal in this pivotal trial without evidence of PORC or re-occurrence of neuromuscular blockade. Effective reversal is critically important to ensure that patients recover quickly and completely, without the risk of breathing difficulties," commented one of the lead investigators involved in the Aurora trial, Professor M. Blobner from the Klinik für Anästhesiologie der Technischen Universität München, Germany.
Reversal agents are used during general anesthesia to reverse the effects of muscle relaxants, also called neuromuscular blocking agents (NMBAs). Reversal of neuromuscular blockade is used to reduce the risk of PORC or re-occurrence of muscle relaxation.

Phase III Trial Overview

The international, randomised, multicenter, parallel-group Aurora trial was conducted at 13 European centers and enrolled 198 patients. In the trial sugammadex was administered at reappearance of T2 and achieved significantly faster recovery of the T4/T1 ratio to 0.9 compared with neostigmine. Median time to recovery was 1.4 minutes (0.9-5.4; p<0.0001) for sugammadex versus 17.6 minutes (3.7-106.9; p<0.0001) for neostigmine following rocuronium administration; and 2.1 minutes (1.2-64.2; p<0.0001) versus 18.9 minutes (2.9-76.2); p<0.0001) respectively following vecuronium administration. There were no clinical events due to PORC or re-curarization reported for either group.1, 2

In total 34 patients from this trial experienced one or more adverse events (AE) that were considered at least possibly related to the study drugs: 14 in the sugammadex group and 20 in the neostigmine group. Most drug-related AEs were mild or moderate. The most commonly reported AEs (>4%) with sugammadex included dry mouth, nausea, vomiting, chills and procedural hypertension. Neostigmine was most commonly associated (>4%) with prolonged neuromuscular blockade, dry mouth, nausea, procedural complication and albumin present in urine.[1, 2]

During the congress, results from three additional Phase III trials - Libra, Spring and Crystal trials - were presented. These trials demonstrated that sugammadex was effective and well tolerated in pediatric patients, in patients with mild or moderate impaired renal function and in comparison with neostigmine-glycopyrrolate after cisatracurium. Most common AEs (>4%) considered at least possibly related to sugammadex in these studies were diarrhoea, anesthetic complication and increased D-glucosaminidase.[3, 4, 5]

In the clinical trials conducted to date, sugammadex has generally demonstrated the ability to reverse shallow and profound depths of rocuronium-induced neuromuscular blockade within 3 minutes, thereby enabling unprecedented control of the onset and offset of skeletal muscle relaxation through the use of both drugs. Sugammadex's global Phase III development program consisting of 5 US trials and 5 European trials - completed recruitment in late 2006. The submission of the registration files for the USA, Europe and Japan are on schedule.
About Organon

Organon creates, manufactures and markets innovative prescription medicines that improve the health and quality of human life. Through a combination of innovation and business partnerships, Organon seeks to leverage its position as a leading biopharmaceutical company in each of its core therapeutic fields: fertility, gynecology and selected areas of anesthesia. It has extensive expertise in neuroscience and a rich and focused R&D program. Research areas also include immunology and specific areas of oncology. Organon products are distributed in over 100 countries worldwide, of which more than 50 have an Organon subsidiary. Organon is the human healthcare business unit of Akzo Nobel.

Organon
http://www.organon.com/authfiles/index.asp
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News6 ; News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.